Dissemin is shutting down on January 1st, 2025

Published in

American Society of Hematology, Blood, 11(112), p. 2578-2578, 2008

DOI: 10.1182/blood.v112.11.2578.2578

Oxford University Press (OUP), International Immunology, 11(21), p. 1225-1237

DOI: 10.1093/intimm/dxp090

Links

Tools

Export citation

Search in Google Scholar

Enhanced B cell activation in the absence of CD81

Journal article published in 2009 by Mrinmoy Sanyal ORCID, Rosemary Fernandez, Shoshana Levy
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Abstract CD81 is a component of the CD19/CD21 coreceptor complex in B cells. This tetraspanin molecule was previously shown to enable membrane reorganization in B cells responding to complement-bound antigens. Here we stimulated B cells via their B cell receptor (BCR) and demonstrate that Cd81−/− B cells fluxed higher intracellular free calcium ion along with increased phosphorylation of PLCγ2 and Syk. The stimulated Cd81−/− B cells also proliferated faster and secreted higher amounts of antibodies. Moreover, activation of the TLR4 pathway in Cd81−/− B cells induced increased proliferation and antibody secretion. Furthermore, Cd81−/− mice mounted a significantly higher immune response to T-cell independent antigens than their wildtype counterparts. Finally, analysis of Cd81−/− B cells that were generated by bone marrow transplantation into Rag1−/− mice confirmed a cell intrinsic hyperactive phenotype. Taken together, these results indicate that CD81 plays a negative role in B cell activation in vitro and in vivo.